Showing 15 posts of 141 posts found.

Indian authorities say J&J’s baby shampoo contains ‘harmful ingredients’

April 1, 2019
Sales and Marketing Cancer, India, J&J, JJ, Johnson & Johnson, Rajasthan, baby shampoo, formaldehyde

Indian authorities in the state of Rajasthan have said that samples taken from Johnson & Johnson’s baby shampoo contained ‘harmful …


Indian measles vaccination campaign saved tens of thousands of lives

March 6, 2019
Research and Development Asia, India, South Asia, infectious diseases, measles, vaccines

A measles vaccination campaign saved tens of thousands of children’s lives in India between 2010 and 2013, according to a …

Indian government set to colour code generic medicines

March 4, 2019
Sales and Marketing India, Indian health, costs, generic medicines, pricing, sales

As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …

Just 10% of those harmed in clinical trials in India receive compensation

January 21, 2019
Sales and Marketing India, WHO, clinical trials, compensation, health

Clinical trials have led to nearly 5,000 deaths in India since 2005, while just a fraction of those affected have …


Sun Pharma’s shares hit six-year low after further whistleblower allegations emerge

January 18, 2019
Medical Communications India, Sun Pharma, pharma

Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …

Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk

January 9, 2019
Manufacturing and Production, Research and Development India, Pfizer, pharma

Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …


J&J’s Baby powder tested in India and Bangladesh

December 21, 2018
Medical Communications Bangladesh, Cancer, India, J&J, JJ, asbestos

Bangladeshi authorities will collect and test samples of Johnson & Johnson’s baby powders for traces of cancer causing asbestos, after …


Indian authorities seize J&J Baby Powder in response to Reuters report

December 19, 2018
Research and Development Cancer, India, J&J, JJ, asbestos, baby powder, regulation

Indian authorities have seized samples of Johnson & Johnson’s Baby Powder from a factory in Baddi in Northern India, after …


India declares Sterling Biotech owners ‘Economic Fugitives’

October 26, 2018
Medical Communications India, Modi, Sandesara, Sterling Biotech, corruption

India’s Enforcement Directorate (ED), the country’s law enforcement agency responsible for tackling financial and economic crimes, is using new powers …


Top Ten most popular articles on this week

August 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10

As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …


Blockchain deployed in fight against fake pharmaceuticals in India

August 22, 2018
Research and Development India, NITI, blockchain, pharma, technology

Indian policymakers in collaboration with an Indian hospital chain and an American multinational, have initiated plans to deploy blockchain technology …


Indian biotech owner detained in Dubai over £550m fraud allegations

August 16, 2018
Medical Communications Dubai, Gujurat, India, Sterling Biotech, UAE, fraud

Indian businessman Nitin Sandesara, the owner of the Gujarat-based pharmaceutical company Sterling Biotech, has been detained in Dubai in relation …


Wockhardt launches $40m manufacturing plant in Dubai

July 30, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma

Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …


China opens market to Indian drugs with reduced tariffs

July 10, 2018
Manufacturing and Production, Sales and Marketing China, India, pharma

India and China have reached an agreement aimed at reducing tariffs on Indian pharmaceuticals going between the world’s two most …


AstraZeneca’s Imfinzi becomes India’s first available immunotherapy for lung cancer

June 22, 2018
Medical Communications, Sales and Marketing AstraZeneca, Imfinzi, India, NSCLC, lung cancer, pharma

In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi (durvalumab) has secured approval in …

Latest content